Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways (Resistance to Targeted Anti-Cancer Therapeutics, 15)
$162.68
Price when purchased online
Free shipping
Free 30-day returns
Sold and shipped by annoncesclassees.lequotidiendumedecin.fr
We aim to show you accurate product information. Manufacturers, suppliers and others provide what you see here.
$162.68
Price when purchased online
Free shipping
Free 30-day returns
Sold and shipped by annoncesclassees.lequotidiendumedecin.fr
Free 30-day returns Details
Product details
| Management number | 233414302 | Release Date | 2026/06/27 | List Price | $65.07 | Model Number | 233414302 | ||
|---|---|---|---|---|---|---|---|---|---|
| Category | |||||||||
This volume comprehensively covers the multiplicity and diversity of mechanisms underlying patient resistance to currently approved anti-cancer drugs, including tyrosine kinase inhibitors and monoclonal antibodies, blockers of growth factor receptors and their downstream pathways, which play essential functions in cancer progression. Each chapter will cover a specific group of targets and the cognate drugs, along with molecular modes of innate and evolving resistance. Read more
| ASIN | 3319679309 |
|---|---|
| ISBN10 | 9783319679303 |
| ISBN13 | 978-3319679303 |
| Edition | 1st ed. 2018 |
| Language | English |
| Publisher | Springer |
| Dimensions | 6.14 x 0.63 x 9.21 inches |
| Item Weight | 1.2 pounds |
| Print length | 262 pages |
| Publication date | April 10, 2018 |
Bestseller ranking
Oncology
Customers who viewed this product also viewed
Mother's Day Candy & Chocolate
Correction of product information
If you notice any omissions or errors in the product information on this page, please use the correction request form below.
Correction Request Form